|
|
Article: United States Patent and Trademark Office Confirms Validity of Osteotech's United States Patent 5,676,146.
- Article from:
- BIOTECH Patent News
- Article date:
- March 1, 2008
CopyrightCOPYRIGHT 2008 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Osteotech, Inc. (Eatontown, NJ), a leader in the emerging field of biologic solutions for regenerative medicine, announced that the United States Patent and Trademark Office has confirmed the validity of its United States Patent 5,676,146. The '146 patent covers mixtures of a radiolucent material, such as demineralized bone, with a radiopaque material, such as nondemineralized or partially demineralized bone, that is provided in sufficient quantity to be used as a radiographic marker. The Patent Office's reexamination certificate also includes four new claims.
"We are pleased that the United States Patent and Trademark Office has confirmed the validity of our ...